Objectives: to undertake the cultural adaptation of, and to evaluate the measurement properties of, the Brazilian version of the Self-efficacy for Appropriate Medication Adherence Scale in coronary heart disease (CHD) patients, with outpatient monitoring at a teaching hospital. Method: the process of cultural adaptation was undertaken in accordance with the international literature. The data were obtained from 147 CHD patients, through the application of the sociodemographic/ clinical characterization instrument, and of the Brazilian versions of the Morisky Self-Reported Measure of Medication Adherence Scale, the General Perceived Self-Efficacy Scale, and the Selfefficacy for Appropriate Medication Adherence Scale. Results: the Brazilian version of the Selfefficacy for Appropriate Medication Adherence Scale presented evidence of semantic-idiomatic, conceptual and cultural equivalencies, with high acceptability and practicality. The floor effect was evidenced for the total score and for the domains of the scale studied. The findings evidenced the measure's reliability. The domains of the Brazilian version of the Self-efficacy for Appropriate Medication Adherence Scale presented significant inverse correlations of moderate to strong magnitude between the scores of the Morisky scale, indicating convergent validity, although correlations with the measure of general self-efficacy were not evidenced. The validity of known groups was supported, as the scale discriminated between "adherents" and "non-adherents" to the medications, as well as to "sufficient dose" and "insufficient dose". Conclusion: the Brazilian version of the Self-efficacy for Appropriate Medication Adherence Scale presented evidence of reliability and validity in coronary heart disease outpatients.
Introduction
Although it is highly prevalent worldwide (1) , recent studies indicate that the advances in the treatment of Coronary Heart Disease (CHD) have contributed to a decline observed in the rates of hospitalization and in mortality through Acute Myocardial Infarction (AMI) (1) (2) . Evidence demonstrates the efficacy of the use of cardioprotective therapy (Beta blockers,
Angiotensin-Converting
Enzyme Inhibitors (ACEinhibitors) or Angiotensin-Receptor Blockers (ARBs), statins and antiplatelets) in the secondary prevention of CHD, the combined use of this therapy being widely recommended (3) . In addition to this, the use of these medications was associated with the reduction in the relative risk of death through CHD (2) (3) . In conjunction with the cardioprotective drugs, the use of medications for relieving symptoms is also related to the patients' greater tolerance to the symptoms of CHD (1, 3) . As a result, the prognosis of CHD is closely related to adherence to the cardioprotective medications and to medications which relieve the symptoms.
Adherence, is defined as the extent to which the patients follow the guidance for the treatment which they are provided with by the doctor and/or other health professionals (4) . Therefore, nonadherence occurs when the patient's behavior does not coincide with these recommendations (5) .
For better comprehension of the construct of medication adherence, some theories have been utilized (6) , among them Bandura's Social-Cognitive Theory; self-efficacy is this theory's central concept.
Self-efficacy may be defined as a belief or trust that one can successfully undertake a specific action, in order to achieve the desired result (7) .
The complexity of medication adherence goes beyond understanding the construct itself, and encompasses the extreme difficulty involved in its accurate measurement. Various methods are available in the literature (8) , including the self-reported scales.
Among the reliable and valid tools for evaluation of selfefficacy, for the behavior of adherence, the Self-efficacy for Appropriate Medication Adherence Scale (SEAMS) (9) , an American scale, stands out. This was constructed in order to assess self-efficacy for medication adherence among individuals with low educational levels. This scale presented adequate measurement properties, when applied in 436 patients with CHD and other comorbidities. The authors do not know of any selfreported instruments for the measurement of selfefficacy, for the behavior of medication adherence, in the Brazilian context.
As a result, this study's objectives were to undertake the cultural adaptation of the SEAMS to Brazilian Portuguese and assess its measurement properties among patients with CHD being treated on an outpatient basis. The specific objectives were to ascertain practicality, acceptability, ceiling and floor effect, reliability and convergent validity, and known groups validity. This research's findings may guide more efficacious conducts in regard to strengthening the selfefficacy for adherence to drug therapy among coronary heart disease (CHD) patients.
Methods
The methodological procedure of cultural adaptation
The following stages were used for the process of translation and adaptation: translation -following the obtaining of consent from the author, the SEAMS was translated to Portuguese by two independent bilingual translators whose mother tongue is Brazilian
Portuguese, only one of these being informed about the scale's concepts and objectives (10) ; synthesis of the translations -the translated versions (T 1 and T 2 ) were analyzed and compared by the researchers and by a professional mediator-translator (10) . The discrepancies were analyzed until consensus was obtained -the in relation to the semantic and idiomatic, cultural and conceptual equivalencies (10) and pre-test -the adapted version was applied in 10 patients with CHD being treated on an outpatient basis. After responding to each item of the scale, the participants were interviewed in order to investigate the difficulties perceived in relation to the understanding of the statements and the response scale, as well as to detect terms which were difficult to understand.
Methodological procedures for evaluation of the measurement properties
The research locale
The study was undertaken in the cardiology outpatient center -Ischemic Heart Disease subspeciality
Data collection procedure
The data were obtained by the researcher, individually, in a private environment, in accordance with the stages shown below. 
Data collection instruments
Instrument for sociodemographic and clinical characterization: the instrument constructed and subjected to content validity in a previous study was used (11) .
Definition of the drug therapy evaluated: the drug therapy evaluated was related to reduction in CHD's morbidity and mortality -lifesaving therapy -(that is, ACE-inhibitors, ARBs, Beta blockers, antiplatelet drugs and statins) and two other drugs which improve the signs and symptoms associated with coronary heart disease (that is to say, digitalis, diuretics and nitrates). interruption of the use of the drug as a result of perceiving improvement, and interruption of the therapy due to perceiving worsening in the clinical situation (12) .
The Brazilian version of the Morisky scale will be used (13) .
In the Brazilian version, a Likert-type response scale and association with time markers (fasting, breakfast and lunch), are not in accordance with the medical prescription. The participants classified in Group I were considered "adherent" and those classified in the other groups, as "nonadherent" (15) .
-General Perceived Self-efficacy Scale (GSE): an instrument created by Schwarzer and Jerusalem (16) , which is unidimensional and made up of 10 items, which refer to how to deal with success in a specified situation.
The participant responds to the instrument through a five point Likert response scale which varies from 1 (totally disagree) to 5 (totally agree). The total score has a variation from 10 to 50. A high score signifies a high perception of self-efficacy. The version adapted to Brazilian Portuguese was used (17) .
-Self-efficacy for Appropriate Medication Adherence (little confident), and 3 (very confident). The total score, which consists of the sum of the responses, can vary between 13 and 39; the higher the score, the greater the self-efficacy for adherence to the drug treatment (9) .
Analysis of the data
-Analysis of the Content Validity: the Content Validity Index (CVI) was used for evaluation of the semanticidiomatic, conceptual and cultural equivalencies.
This measures the proportion of judges who are in agreement regarding the items and general aspects evaluated (10) . The items' relevance and representativity was evaluated, through a Likert-type scale with scores varying between 1 and 4 (1= not relevant or not representative, 2= requiring major revision in order to be representative, 3= requiring minor revision in order to be representative, 4= relevant or representative).
The CVI was calculated through the sum of agreement of the items which received scores of "3" or "4", divided
by the total number of responses. The items with scores of "1" or "2" were revised.
-Descriptive analysis, of the reliability and validity of the participants who responded to all the items (18) . The floor effect, which is equivalent to the 10% of the scale's worst possible results, and the ceiling effect, which corresponds to the 10% of the scale's best possible results, were evaluated (19) .
-Evaluation of reliability: the Cronbach alpha coefficient was used to calculate the internal consistency, with a
Cronbach alpha of >0.70 being established as evidence of satisfactory internal consistency (20) . In order to evaluate the stability of the measure, the Intraclass Correlation Coefficient (ICC) was used, with ICC >0.7
being considered satisfactory (21) .
-Calculation of the construct validity: the convergent construct validity and the validity of known or contrasted groups were tested. In order to estimate the convergent construct validity, Spearman's correlation coefficient was used in order to test the correlation between the scores of the Brazilian versions of the SEAMS, the GSE and the MMAS-4, considering the coefficients of <0.30 to be of weak magnitude, those between 0.30 and 0.50 to be of moderate magnitude, and those >0.50 to be of strong magnitude (22) . Negative correlations of strong magnitude were hypothesized between the domains of the Brazilian version of the SEAMS and the total score for the MMAS-4, and significant positive correlations of strong to moderate magnitude between the SEAMS and the GSE.
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The construct validity of known or contrasted groups was tested through the use of the Mann-Whitney test, in order to ascertain the instrument's capacity to distinguish between the participants classified as appropriate dose or insufficient dose, according to the self-reported measurement of proportion of adherence, as well as those considered to be adherent or nonadherent to the drug therapy, according to the global evaluation of adherence.
It was hypothesized that the participants classified as "nonadherent" and "insufficient dose" would present the lower self-efficacy for medication adherence, according to the proportion of medication adherence.
A level of significance of 5% was adopted.
Ethical aspects
The study was approved by the university's
Research Ethics Committee (Opinion N. 254.844/2013) and all the patients enrolled signed the TFIC.
Results

Methodological procedure of cultural adaptation
The results of the content validation (CVI) evidenced between 0.80 and 1.0 in 11 of the 13 items evaluated. Only items 11 and 12 obtained CVI= 0.60, these being revised in order to obtain consensus between the judges. However, some of the experts made suggestions regarding the presentation of the instrument, which were taken into account. As a result, the design was altered and the numbering was removed from the response scale, this being considered not to be important for the respondents.
The Brazilian version of the SEAMS was evaluated by the Committee of Judges a second time, and submitted to the pre-test stage. In this stage, the respondents reported understanding the items, and denied difficulties for interpreting the response scale.
Descriptive evaluation and evaluation of reliability, and construct validity
Sociodemographic and clinical characterization 
Practicality, acceptability and ceiling and floor effects
The results suggest that the Brazilian version of the SEAMS is an instrument which is easy to apply, with a (Table 2) . Table 4 -Spearman correlation coefficients between the scores of the Brazilian versions of the Self-efficacy for Appropriate Medication Adherence Scale, the Morisky Self-Reported Measure of Medication Adherence Scale and the General Perceived Self-efficacy Scale (n=147). Campinas, SP, Brazil, 2014 *Self-efficacy for Appropriate Medication Adherence Scale (SEAMS); †General Perceived Self-efficacy Scale (GSE); ‡r= correlation coefficient.
Validity of known or contrasted groups
The findings evidenced that the Brazilian version of the SEAMS was able to discriminate between patients who adhered, and those who did not, to the medication therapy, according to the global evaluation of the adherence -which considers, besides how the medication is to be taken (dose, form, frequency and how long for), the care for taking the medications. The data showed that, in both the domains and total score of the SEAMS, the score was significantly greater among those who adhered to the medications, in comparison with the nonadherent group, indicating greater self-efficacy for drug adherence in the adherent group, as previously hypothesized.
In the same way, the Brazilian version of the SEAMS discriminated self-efficacy among patients categorized as adequate dose and those considered as insufficient
Rev. Latino-Am. Enfermagem. 2016;24:e2692 dose, according to the proportion of drug adherence, with higher scores in the SEAMS being observed among those patients categorized as adequate dose in domains 1 and 2 (p=0.0051 and p=0.0125, respectively) and total score (p=0.0012) of the SEAMS, when compared with those with insufficient dose (Table 5) . 
Domains of the SEAMS
Discussion
In this study, the cultural adaptation of the SEAMS was undertaken, and the measurement properties of the Brazilian version of the SEAMS were investigated. The SEAMS is an instrument constructed with the purpose of measuring self-efficacy for medication adherence.
The methodological procedure of cultural adaptation was undertaken in CHD patients, with the semanticidiomatic, conceptual and cultural equivalencies of the Brazilian version of the SEAMS being determined.
A ceiling effect was observed for the total score and for both domains, indicating that the Brazilian version of the SEAMS may not be sensitive for detecting improvement of self-efficacy. However, the Brazilian version of the SEAMS may be potentially sensitive and responsive to measuring worsening, as the floor effect was not observed. One possible explanation for this finding may be related to the instrument's response scale, whose highly similar options may not have made it possible for participants to differentiate the alternatives. In previous studies (9, 23) , in which the SEAMS was applied, the evaluation of the instrument's ceiling and floor effect is not found. The present study's findings need to be ratified, as they imply the limitation of its use in experimental studies in order to evaluate the effect of interventions for the strengthening of selfefficacy, for medications adherence.
The majority of the domains of the SEAMS presented evidence of internal consistency, with the Cronbach alpha oscillating between 0.85 and 0.90, a finding observed in a previous study involving patients with coronary heart disease (9) . The item/total correlation analyses, as well as the observation that the removal of items does not significantly improve the Cronbach alpha coefficient, reinforce the homogeneity of the items in each domain. The reliability was also tested through the test-retest, with evidence being obtained of the measure's temporal stability. However, studies involving the application of the SEAMS in other populations, for evaluation of the instrument's measurement properties,
were not found in the literature.
In the present study, evidence of the construct validity of the SEAMS was supported by the analyses of correlation between the SEAMS scores and those of the MMAS-4. However, correlations were not found between the domains of the SEAMS and the measure of general self-efficacy through the GSE. This absence of correlation may be explained by the fact that this scale measures self-efficacy in a generic way, that is, the items of the scale refer to how to deal with success in a specified situation, while the SEAMS evaluate self-Pedrosa RBS, Rodrigues RCM.
efficacy for a specific behavior -medication adherence.
However, it is emphasized that negative correlations of moderate to strong magnitude were observed between the SEAMS and the MMAS-4, which suggests convergent construct validity (9) .
In relation to the validity of known groups, it was observed that the dimensions and total score of the SEAMS discriminated between CHD patients classified as "adherent" and "non-adherent". Therefore, the sensitivity of the SEAMS, in the detection of differences between the groups, suggests that this instrument may be responsive, that is, capable of measuring changes in self-efficacy for medication adherence, over time. Data
were not found in the literature relating to the validity of known groups of the SEAMS.
Self-efficacy is an important construct which can, partly, explain the behavior of medication adherence in CHD patients, as well as being particularly relevant as it is potentially modifiable (7) , being able to be the basis for the development of interventions related to behavioral change (24) .
The measurement provided by the SEAMS has potential applications for clinical practice and for research. with a low self-efficacy (25) .
As a research tool, the measurement of self-efficacy provided by the SEAMS could be a valuable variable of outcome, which could be measured over time in response to a cognitive or educational behavioral intervention, providing evidence regarding the effect of interventions, as well as contributing to a better understanding of the constructs which determine adherence. In this regard, the scale may be used in studies which aim to extend knowledge regarding the mediating and/or moderating variables of this complex behavior.
As limitations, the absence in the present study . Although an objective measurement of medication adherence was not used, it is emphasized that more than one self-reported measure was used, with a view to obtaining a more accurate evaluation of medication adherence.
As a result, this study provides a tool with evidence of reliability and validity for measuring self-efficacy, for medication adherence, which could be useful in the evaluation of this construct, after nursing interventions directed towards the improvement of self-efficacy for medication adherence.
Conclusion
This study provides evidence that the Brazilian 
